Showing results (141-150 of 213) with videos related to
Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|June 12, 2014
Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptorsKangsheng Tu, Jiachu Li, Vikas K Verma, et al.Cancer Immunology Research|August 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and LongevityHaidong Dong, Hyoungjun Ham, Whitney Barham, et al.Cell|February 10, 2010
Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1Bingke Yu, Ilídio R S Martins, Pilong Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2011
Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cellsDeborah A Klos Dehring, Fiona Clarke, Brendon G Ricart, et al.Cancer Cell|January 18, 2005
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesisMartin E Fernandez-Zapico, Natalia C Gonzalez-Paz, Ellen Weiss, et al.NPJ Precision Oncology|June 7, 2018
Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathwayXiaoyu Xiang, Yuanguo Wang, Hongbin Zhang, et al.The Journal of Biological Chemistry|August 26, 2011
High cell surface death receptor expression determines type I versus type II signalingXue Wei Meng, Kevin L Peterson, Haiming Dai, et al.Cell Reports|June 4, 2020
Inactivation of Rho GTPases by Burkholderia cenocepacia Induces a WASH-Mediated Actin Polymerization that Delays Phagosome MaturationGlenn F W Walpole, Jonathan D Plumb, Daniel Chung, et al.Proceedings of the National Academy of Sciences of the United States of America|August 31, 2021
SNX27-FERM-SNX1 complex structure rationalizes divergent trafficking pathways by SNX17 and SNX27Xin Yong, Lin Zhao, Wenfeng Hu, et al.Journal of Medicinal Chemistry|April 3, 2009
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cellsIrina N Gaisina, Franck Gallier, Andrei V Ougolkov, et al.Pageof 22